您的位置: 首页 > 农业专利 > 详情页

PYRAZOLONE COMPOUNDS FOR TREATING CEREBROVASCULAR DISORDERS
专利权人:
Mitsubishi Tanabe Pharma Corporation
发明人:
申请号:
EP05772671.3
公开号:
EP1793821B1
申请日:
2005.08.10
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
A drug includes the relevant cranial vascular disease of Clinical Therapeutic Effects of Edaravone Brain circlulation insufficient (such as Ischemic Stroke), the structural formula (I) of pyrazolinone compounds comprising pharmaceutical effective amount: or its pharmaceutically acceptable salt or pseudopolymorphic forms, give control dosage, to make the plasma concentration of its original shape keep constant, therefore higher effect can be shown by this compound in predetermined period.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充